Tepnel Pharma Services has added to its Molecular Genetic Services portfolio with Hologic’s proprietary Invader and Invader Plus technology. The new technology enables Tepnel to offer customers a more cost effective and high throughput genotyping and copy number variation (CNV) service, according to the company. Tepnel is a division of Hologic.
The Invader chemistry platform is an isothermal, DNA-probe based system used in disease detection, genotyping and CNV assays. Invader Plus couples target amplification with specificity. Invader chemistry is currently used in multiple FDA-approved and CE-marked products and is used by laboratories worldwide for their clinical diagnostic, research and high throughput genotyping needs.
Dr. Bob Holt, Molecular Genetic Services manager, Tepnel Pharma Services, commented, “We are excited to offer Invader as part of our Molecular Genetic Service portfolio. The highly versatile nature of the technology will allow Tepnel to expand into the AgBio space and extend our capabilities in biomarker discovery, clinical assay development, and companion diagnostic development in support of preclinical, clinical and personalized medicine studies.”
Tepnel Adds Invader Technology
By Gil Roth
Published October 14, 2013
blog comments powered by Disqus